The Reserve Bank of India has shortened the timeline for exporters to repatriate earnings, reducing foreign currency realisation to 9 months from 15 months, effective October 1, 2026. The policy aims to improve dollar liquidity. Investors should note this may squeeze working capital for businesses with long international payment cycles.
The Reserve Bank of India (RBI) is changing how quickly companies must bring home their foreign earnings. Starting October 1, 2026, the limit for foreign currency proceeds will drop to 9 months, down from the previous 15 months. For exports billed in Indian rupees, the deadline is now 12 months, reduced from 18 months. These rules, governed by the Foreign Exchange Management Act (FEMA), dictate how much time an exporter has between shipping goods or providing services and receiving the payment in India. By shrinking these windows, the central bank is effectively forcing faster movement of money into the domestic banking system.
This change follows a period of significant foreign inflow. Earlier this year, the RBI reported that previous initiatives successfully helped attract $144 billion in foreign inflows. The new move suggests the regulator wants to ensure this liquidity remains stable and that export earnings are accounted for more quickly. This helps with the management of the country's foreign exchange reserves and ensures that money earned abroad is repatriated in a predictable timeframe.
For investors, this adjustment could impact working capital management for many listed companies. Businesses often rely on credit terms with international buyers. If a company typically collects payment in 12 months, it will now face a hurdle under the new 9-month rule for foreign currency receipts. This may require companies to renegotiate payment terms or tighten credit policies with overseas customers to ensure they receive funds within the regulatory window.
Sectors with long-cycle projects, such as capital goods, heavy engineering, and specialized manufacturing, might feel this the most. These industries often have long timelines for project completion and payment. Pharma companies that deal with complex export contracts could also face pressure if their collection cycles are currently longer than the new nine-month limit. Investors may want to track how these companies adjust their credit cycles to meet the new regulatory timelines. If they cannot collect payments faster, it could lead to higher short-term debt requirements to bridge the cash flow gap.
The next important factor for investors to monitor will be how companies communicate their credit collection strategies in upcoming earnings calls or management disclosures. The market will also watch if any specific export-oriented sectors seek extensions or clarifications from the regulator regarding these tighter time limits.